Lakshmanan Krishnamurti Named Chief of Pediatric Hematology, Oncology, and Bone Marrow Transplant at Yale New Haven Children’s Hospital and Smilow Cancer Hospital
Lakshmanan Krishnamurti, MD, has been named Chief of Pediatric Hematology, Oncology, and Bone Marrow Transplant at Yale New Haven Children’s Hospital and Leader of the Smilow Cancer Hospital Pediatric Hematology/Oncology Program.
- June 29, 2021Source: OncLive
The landscape of immunotherapy biomarkers is rapidly evolving, and future developments are likely to have an impact on patients and clinicians alike, said Kurt A. Schalper, MD, PhD, in a virtual presentation during the 5th Annual International Congress on Oncology and Pathology.
- June 20, 2021Source: Yale Scientific
Researchers from the Yale Department of Immunology and Yale Cancer Center have recently developed a mouse model that displays enhanced human erythropoiesis and mature RBC survival to help them better study human blood disorders.
- May 21, 2021
The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of applied research and technology in the life sciences.
- May 06, 2021
Novel Gene Identified as Genetic Cause of Portal Hypertension
- April 10, 2021
Yale Cancer Center Study Provides New Insights into Resistance to Immune Checkpoint Inhibitors in Lung Cancer
New research by Yale Cancer Center shows insights into modeling resistance to immune checkpoint inhibitors, a form of cancer immunotherapy.
- April 05, 2021Source: Medicine@Yale
YSM’s clinical, scientific, and educational efforts all overcame major challenges.
- March 15, 2021Source: Yale Daily News
Yale lab develops revolutionary RNA vaccine for malaria
- March 12, 2021
A case study in NPJ Precision Oncology used whole-exome sequencing (WES) to map out the genetic structure of a rare case of gliosarcoma.
- March 08, 2021Source: The BMJ
A vaccine against malaria: five minutes with . . . Richard Bucala